Works by Palaparthy, Ramesh

Results: 9

POPULATION PK ANALYSIS TO GUIDE DOSING WINDOW FOLLOWING LENACAPAVIR SC ADMINISTRATION.

Published in:

Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 198

By:

Shaik, Naveed A.;
Bellanti, Francesco;
Comisar, Craig;
Rhee, Martin S.;
Girish, Sandhya;
Palaparthy, Ramesh;
Singh, Renu

Publication type:

Article

Pharmacokinetics, safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kg.

Published in:

Journal of the International AIDS Society, 2025, v. 28, n. 2, p. 1, doi. 10.1002/jia2.26414

By:

Natukunda, Eva;
Gaur, Aditya H.;
Kosalaraksa, Pope;
Hellström, Elizabeth;
Strehlau, Renate;
Liberty, Afaaf;
Cox, Stephanie;
Leisegang, Rory;
Palaparthy, Ramesh;
Crowe, Susanne;
Vieira, Vinicius;
Kersey, Kathryn;
Rakhmanina, Natella

Publication type:

Article

Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925.

Published in:

International Journal of Neuropsychopharmacology, 2010, v. 13, n. 3, p. 273, doi. 10.1017/S1461145709990642

By:

Graff-Guerrero, Ariel;
Redden, Laura;
Abi-Saab, Walid;
Katz, David A.;
Houle, Sylvain;
Barsoum, Penny;
Bhathena, Anahita;
Palaparthy, Ramesh;
Saltarelli, Mario D.;
Kapur, Shitij

Publication type:

Article

Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium "Long-Acting Injectables" Working Group.

Published in:

Pharmaceutical Research, 2023, v. 40, n. 7, p. 1601, doi. 10.1007/s11095-022-03391-y

By:

Bauer, Andrea;
Berben, Philippe;
Chakravarthi, Sudhir S.;
Chattorraj, Sayantan;
Garg, Ashish;
Gourdon, Betty;
Heimbach, Tycho;
Huang, Ye;
Morrison, Christopher;
Mundhra, Deepak;
Palaparthy, Ramesh;
Saha, Pratik;
Siemons, Maxime;
Shaik, Naveed A.;
Shi, Yi;
Shum, Sara;
Thakral, Naveen K.;
Urva, Shweta;
Vargo, Ryan;
Koganti, Venkat R.

Publication type:

Article

A randomized study comparing the pharmacokinetics of the potential biosimilar PF-06438179/GP1111 with Remicade® (infliximab) in healthy subjects (REFLECTIONS B537-01).

Published in:

Expert Review of Clinical Immunology, 2018, v. 14, n. 4, p. 329, doi. 10.1080/1744666X.2018.1446829

By:

Palaparthy, Ramesh;
Udata, Chandrasekhar;
Hua, Steven Y.;
Yin, Donghua;
Cai, Chun-Hua;
Salts, Stephanie;
Rehman, Muhammad I.;
McClellan, Joseph;
Meng, Xu

Publication type:

Article

Effect of Food Intake or Coadministration With an Acid‐Reducing Agent on Lenacapavir Pharmacokinetics Following Oral Administration.

Published in:

Clinical Pharmacology in Drug Development, 2025, v. 14, n. 4, p. 324, doi. 10.1002/cpdd.1513

By:

Singh, Renu;
Shelton, Mark;
Olson, Isabel;
Ling, John;
West, Steve;
Levy, Jeffrey A.;
Rhee, Martin S.;
Girish, Sandhya;
Palaparthy, Ramesh

Publication type:

Article

A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy.

Published in:

Arthritis Research & Therapy, 2018, v. 20, n. 1, p. N.PAG, doi. 10.1186/s13075-018-1646-4

By:

Cohen, Stanley B.;
Alten, Rieke;
Kameda, Hideto;
Hala, Tomas;
Radominski, Sebastiao C.;
Rehman, Muhammad I.;
Palaparthy, Ramesh;
Schumacher, Karl;
Schmitt, Susanne;
Hua, Steven Y.;
Ianos, Claudia;
Lea Sewell, K.

Publication type:

Article

Pharmacokinetics, safety, and tolerability of inhaled remdesivir in healthy participants.

Published in:

CTS: Clinical & Translational Science, 2023, v. 16, n. 11, p. 2276, doi. 10.1111/cts.13627

By:

Humeniuk, Rita;
Juneja, Kavita;
Chen, Shuguang;
Ellis, Scott;
Anoshchenko, Olena;
Xiao, Deqing;
Share, Aaron;
Johnston, Matthew;
Davies, Santosh;
DeZure, Adam;
Llewellyn, Joe;
Osinusi, Anu;
Winter, Helen;
Girish, Sandhya;
Palaparthy, Ramesh;
Dresser, Mark

Publication type:

Article

Pharmacokinetics, Disposition, and Biotransformation of [14C]Lenacapavir, a Novel, First-in-Class, Selective Inhibitor of HIV-1 Capsid Function, in Healthy Participants Following a Single Intravenous Infusion.

Published in:

Clinical Pharmacokinetics, 2024, v. 63, n. 2, p. 241, doi. 10.1007/s40262-023-01328-1

By:

Weber, Elijah;
Subramanian, Raju;
Rowe, William;
Graupe, Michael;
Ling, John;
Shen, Gong;
Begley, Rebecca;
Sager, Jennifer;
Wolckenhauer, Scott;
Rhee, Martin;
Palaparthy, Ramesh;
Singh, Renu

Publication type:

Article

Works by Palaparthy, Ramesh

POPULATION PK ANALYSIS TO GUIDE DOSING WINDOW FOLLOWING LENACAPAVIR SC ADMINISTRATION.

Pharmacokinetics, safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kg.

Blockade of [<sup>11</sup>C](+)-PHNO binding in human subjects by the dopamine D<sub>3</sub> receptor antagonist ABT-925.

Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium "Long-Acting Injectables" Working Group.

A randomized study comparing the pharmacokinetics of the potential biosimilar PF-06438179/GP1111 with Remicade® (infliximab) in healthy subjects (REFLECTIONS B537-01).

Effect of Food Intake or Coadministration With an Acid‐Reducing Agent on Lenacapavir Pharmacokinetics Following Oral Administration.

A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy.

Pharmacokinetics, safety, and tolerability of inhaled remdesivir in healthy participants.

Pharmacokinetics, Disposition, and Biotransformation of [<sup>14</sup>C]Lenacapavir, a Novel, First-in-Class, Selective Inhibitor of HIV-1 Capsid Function, in Healthy Participants Following a Single Intravenous Infusion.